Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0109 Transporter Info | ||||
Gene Name | SLC16A5 | ||||
Transporter Name | Monocarboxylate transporter 6 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOS |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Protein c-Fos | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Cervix; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein c-Fos (FOS) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
JUNB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Transcription factor JunB | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunB (JUNB) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix; Colon; Coronary artery; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
NFE2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Transcription factor NF-E2 45 kDa subunit | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor NF-E2 45 kDa subunit (NFE2) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
CLOCK |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Circadian locomoter output cycles protein kaput | Transcription Factor Info | ||||
Tissue |
Bone; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Circadian locomoter output cycles protein kaput (CLOCK) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
MAX |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Protein max | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Cervix; Colon; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein max (MAX) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
MXI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Max-interacting protein 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-interacting protein 1 (MXI1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
TFAP2C |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in breast cancer condition | [5] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC16A5 gene in breast cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in prostate cancer condition | [6] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC16A5 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Estrogen receptor (ESR1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in health condition | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC16A5 gene in health condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
HNF4G |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-gamma | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 4-gamma (HNF4G) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
RXRG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Retinoic acid receptor RXR-gamma | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Retinoic acid receptor RXR-gamma (RXRG) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in breast cancer condition | [8] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLC16A5 gene in breast cancer condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in gastric cancer condition | [9] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of SLC16A5 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 13 TF(s) Regulating This DT |
|||||
EGR1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in erythroleukemia condition | [10] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC16A5 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Colon; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
HINFP |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Histone H4 transcription factor | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Histone H4 transcription factor (HINFP) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
KLF5 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in gastric cancer condition | [9] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC16A5 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
MECOM |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Histone-lysine N-methyltransferase MECOM | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Histone-lysine N-methyltransferase MECOM (MECOM) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
SP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Tissue |
Blood; Colon; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Sp1 (SP1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ZNF384 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Zinc finger protein 384 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 384 (ZNF384) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HOXB13 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Homeobox protein Hox-B13 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Homeobox protein Hox-B13 (HOXB13) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
PBX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.2: Paired box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PAX5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Paired box protein Pax-5 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Paired box protein Pax-5 (PAX5) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Breast; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOXA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in health condition | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC16A5 gene in health condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOXM1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOXO3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Forkhead box protein O3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein O3 (FOXO3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 13 TF(s) Regulating This DT |
|||||
EHF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
ETS homologous factor | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS homologous factor (EHF) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ELF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Liver; Lung; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ELK3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in hypoxia condition | [11] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) has been reported to bind to the transcription of SLC16A5 gene in hypoxia condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Tissue |
Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ELK4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
ETS domain-containing protein Elk-4 | Transcription Factor Info | ||||
Tissue |
Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS domain-containing protein Elk-4 (ELK4) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
ETS2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Protein C-ets-2 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-2 (ETS2) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC16A5 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Cervix; Embryo; Liver; Lung; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
SPI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in acute promyelocytic leukemia condition | [13] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC16A5 gene in acute promyelocytic leukemia condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.6: TEA domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TEAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Transcriptional enhancer factor TEF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional enhancer factor TEF-3 (TEAD4) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in colorectal cancer condition | [14] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC16A5 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
Class4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFYA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit alpha | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit alpha (NFYA) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SRF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Serum response factor | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Serum response factor (SRF) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [3] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in fibrosarcoma condition | [15] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC16A5 gene in fibrosarcoma condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in glioblastoma multiforme condition | [16] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC16A5 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in health condition | [17] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC16A5 gene in health condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC16A5 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC16A5 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Monocarboxylate transporter 6. | |||||
RUNX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [1] | ||||
TF Protein Name |
Runt-related transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 3 (RUNX3) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [4] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC16A5 gene | [2] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Brain; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC16A5 gene, which in turn affects the expression or function of the drug transporter Monocarboxylate transporter 6. | |||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC16A5 gene in human embryonic stem cells (hESCs) condition | [18] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC16A5 gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Monocarboxylate transporter 6. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.